Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Charlotte Carlier

16 Results

2021

Debulking and HIPEC for ovarian cancer : effects of perfusion temperature on morbidity and cisplatin pharmacokinetics

Jesse DemuytereCharlotte CarlierWouter WillaertPhilippe TummersHannelore DenysOlivier Van KerschaverJoseph WeertsSarah CosynsWim Ceelen

2020

PKPD modeling and dosing considerations in advanced ovarian cancer patients treated with cisplatin-based intraoperative intraperitoneal chemotherapy

Feifan XieJan Van BocxlaerPieter ColinCharlotte CarlierOlivier Van KerschaverJoseph WeertsHannelore DenysPhilippe TummersWouter WillaertWim Ceelen et al.

A1 Journal Article in AAPS JOURNAL

2019

A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy

Margo SteuperaertCharlotte DebbautCharlotte CarlierOlivier De WeverBenedicte DescampsChristian VanhoveWim CeelenPatrick Segers

A1 Journal Article in DRUG DELIVERY

2018

A model-based analysis of the kinetics of leukocytes in stage III ovarian cancer patients treated with neo-adjuvant chemotherapy, cytoreductive surgery and cisplatin-based intraperitoneal chemoperfusion

Feifan XieCharlotte CarlierWim CeelenJan Van BocxlaerAn VermeulenPieter Colin

Intraperitoneal drug delivery in ovarian cancer

Charlotte CarlierWim CeelenFrank Vanhaecke

Pharmacokinetics and tissue transport of intraperitoneal chemotherapy

Nick LagastCharlotte CarlierWim Ceelen

A1 Journal Article in SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA

Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts

Charlotte CarlierAnne HoorensKaat De ClercqSilvia GiordanoLavinia MorosiEnrico DavoliJo Van DorpeChris VervaetFrank VanhaeckeWim Ceelen

2017

Tumour tissue transport after intraperitoneal anticancer drug delivery

Charlotte CarlierAda MathysEmiel De JaeghereMargo SteuperaertOlivier De WeverWim Ceelen

A1 Journal Article in INTERNATIONAL JOURNAL OF HYPERTHERMIA

2016

Analysis of specific platinum-DNA adducts after clinical intraoperative intraperitoneal chemoperfusion of ovarian cancer patients

Charlotte CarlierJürgen ThomaleWim Ceelen

Analysis of specific platinum-DNA adducts after clinical intraoperative intraperitoneal chemoperfusion of ovarian cancer patients

Charlotte Carlier

Assessment of ovarian cancer tumors treated with intraperitoneal cisplatin therapy by nanoscopic X-ray fluorescence imaging

Brecht LaforceCharlotte CarlierBart VekemansJulie VillanovaRémi TucoulouWim CeelenLaszlo Vincze

A1 Journal Article in SCIENTIFIC REPORTS

Low dispersion LA-ICP-MS cells : high-resolution tissue imaging and single cell analysis

Stijn Van MalderenFrank VanhaeckeEva VerguchtLaszlo VinczeColin JanssenTessa BuckleCharlotte CarlierWim Ceelen

Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer

Charlotte CarlierBrecht LaforceStijn Van MalderenFélix GremonprezRemi TucoulouJulie VillanovaOlivier De WeverFrank VanhaeckeWim CeelenLaszlo Vincze

A1 Journal Article in JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Platinum distribution of platinum after clinical (H)IPEC using laser ablation inductively coupled plasma mass spectrometry

Charlotte CarlierStijn Van MalderenFrank VanhaeckeWim Ceelen

Preclinical activity of melflufen (J1) in ovarian cancer

Charlotte CarlierSara StreseKristina ViktorssonEbba VelanderPeter NygrenMaria UustaluTherese JunttiRolf LewensohnRolf LarssonJack Spira et al.

A1 Journal Article in ONCOTARGET

2015

Data on in vivo selection of SK-OV-3 Luc ovarian cancer cells and intraperitoneal tumor formation with low inoculation numbers

Elly De VlieghereCharlotte CarlierWim CeelenMarc BrackeOlivier De Wever

A2 Journal Article in DATA IN BRIEF